Matt Ebner

Biotech Lupin Introduces Risperidone Extended-Release Injection in the U.S.

Lupin Limited has announced the launch of Risperidone for Extended-Release Injectable Suspension in the United States, strengthening its presence in t

---

Biotech Lupin Surpasses Global Sustainability Benchmarks with S&P Global ESG Score of 91

Lupin Limited (Lupin), a leading global pharmaceutical organization, today announced that it has secured an S&P Global ESG Score of 91 for 2025, significantly h…

---

Biotech Lupin Receives Establishment Inspection Report from U.S. FDA for Aurangabad (CSN) Facility

Mumbai, November 12, 2025: Lupin Limited (Lupin), a global pharmaceutical major, announced today that it has received the Establishment Inspection Rep

---

Business Lupin’s Pune Bioresearch Centre Completes U.S. FDA Inspection with Zero Observations

Mumbai, November 8, 2025: Lupin Limited, a global pharmaceutical major, reported that the U.S. Food and Drug Administration (U.S. FDA) has concluded a

---

Business Lupin’s Pithampur Unit-3 Receives EIR from the U.S. FDA

Mumbai, November 5, 2025: Lupin Limited, a globally respected pharmaceutical company, announced today that it has received an Establishment Inspection

---

Health Lupin Gets Tentative U.S. FDA Nod for Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide Tablets

Mumbai, Naples, February 3, 2025: Lupin Limited (Lupin), a leading global pharmaceutical company, announced that it has received tentative approval fr

---

Business Lupin Recognized Among Top Sustainability Leaders in S&P Global Yearbook 2025

Mumbai, February 27, 2025: For the second consecutive year, Lupin Limited (Lupin) has earned a coveted place in the S&P Global Sustainability Year

---

Business Lupin Recognized by CDP with “A-” Rating for Excellence in Environmental Sustainability

Mumbai, February 19, 2025: Pharmaceutical leader Lupin Limited has been awarded an “A-” leadership rating by CDP for its performance in climate ch

---

Business Lupin’s Somerset Facility Gets EIR Nod from U.S. FDA

Mumbai, February 21, 2025: Pharmaceutical major Lupin Limited has confirmed the receipt of an Establishment Inspection Report (EIR) from the U.S. FDA

---

Business Rivaroxaban 2.5 mg Tablets Now Available in U.S. by Lupin

Global pharmaceutical company Lupin Limited today confirmed the launch of Rivaroxaban Tablets USP, 2.5 mg, in the U.S., post the final FDA approval of

---